{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:48:04Z","timestamp":1790340484218,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["068590"],"award-info":[{"award-number":["068590"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000328","name":"Leukaemia Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLK3-CT-2001-00225"],"award-info":[{"award-number":["QLK3-CT-2001-00225"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["101740"],"award-info":[{"award-number":["101740"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["106430"],"award-info":[{"award-number":["106430"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.2353\/ajpath.2007.070240","type":"journal-article","created":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T21:45:13Z","timestamp":1186177513000},"page":"893-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Myasthenia Gravis Thymus"],"prefix":"10.1016","volume":"171","author":[{"given":"Maria I.","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Niks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scaravilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurea","family":"Canelhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2007.070240_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol Rev"},{"key":"10.2353\/ajpath.2007.070240_bib3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2007.070240_bib4","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.2353\/ajpath.2007.070240_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2007.070240_bib6","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.2353\/ajpath.2007.070240_bib7","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2007.070240_bib9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/01.wnl.0000188881.46043.44","article-title":"MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase","volume":"65","author":"Ohta","year":"2005","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/01.WNL.0000041625.41937.FF","article-title":"AChR phosphorylation and indirect inhibition of AChR function in seronegative MG","volume":"59","author":"Plested","year":"2002","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","article-title":"Clinical and serological study of myasthenia gravis in HuBei Province, China","volume":"78","author":"Zhang","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.2353\/ajpath.2007.070240_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jneuroim.2005.01.009","article-title":"Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitization","volume":"162","author":"Spreadbury","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2007.070240_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0896-8411(88)90067-4","article-title":"Myasthenia gravis thymus: clinical, histological and culture correlations","volume":"1","author":"Schluep","year":"1988","journal-title":"J Autoimmun"},{"key":"10.2353\/ajpath.2007.070240_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(02)00038-3","article-title":"Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis","volume":"125","author":"Roxanis","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2007.070240_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(00)00415-X","article-title":"True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis","volume":"112","author":"Roxanis","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2007.070240_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","article-title":"Scenarios for autoimmunization of T and B cells in myasthenia gravis","volume":"998","author":"Shiono","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2007.070240_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI7558","article-title":"Analysis of the human thymic perivascular space during aging","volume":"104","author":"Flores","year":"1999","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2007.070240_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005792-194902000-00002","article-title":"The pathology of the thymus in myasthenia gravis: a study of 35 cases","volume":"28","author":"Castleman","year":"1949","journal-title":"Medicine"},{"key":"10.2353\/ajpath.2007.070240_bib20","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1749-6632.1998.tb10954.x","article-title":"Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus","volume":"841","author":"MacLennan","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"10.2353\/ajpath.2007.070240_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2007.070240_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(77)92118-3","article-title":"Intrathymic pathogenesis and dual genetic control of myasthenia gravis","volume":"1","author":"Wekerle","year":"1977","journal-title":"Lancet"},{"key":"10.2353\/ajpath.2007.070240_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2007.070240_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.47.6.1552","article-title":"A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis","volume":"47","author":"Beeson","year":"1996","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2007.070240_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2007.070240_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","article-title":"Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells","volume":"17","author":"Monsinjon","year":"2003","journal-title":"FASEB J"},{"key":"10.2353\/ajpath.2007.070240_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0897.1988.tb00228.x","article-title":"Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen","volume":"18","author":"Hsi","year":"1988","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"10.2353\/ajpath.2007.070240_bib31","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.147.9.3005","article-title":"Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity","volume":"147","author":"Adams","year":"1991","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2004.02086.x","article-title":"Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects","volume":"114","author":"Davies","year":"2005","journal-title":"Immunology"},{"key":"10.2353\/ajpath.2007.070240_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2640001","article-title":"Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects","volume":"264","author":"Morgan","year":"1989","journal-title":"Biochem J"},{"key":"10.2353\/ajpath.2007.070240_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01837366","article-title":"Membrane proteins that protect against complement lysis","volume":"15","author":"Morgan","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.2353\/ajpath.2007.070240_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/path.1711700204","article-title":"Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles","volume":"170","author":"Lampert","year":"1993","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2007.070240_bib36","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1172\/JCI116069","article-title":"Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus","volume":"90","author":"French","year":"1992","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2007.070240_bib37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.070240_bib38","first-page":"402","article-title":"Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma)","volume":"27","author":"Sprott","year":"2000","journal-title":"J Rheumatol"},{"key":"10.2353\/ajpath.2007.070240_bib39","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.174.4.2353","article-title":"Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation","volume":"174","author":"van Beek","year":"2005","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib40","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V94.5.1673","article-title":"Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition","volume":"94","author":"Mason","year":"1999","journal-title":"Blood"},{"key":"10.2353\/ajpath.2007.070240_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-5728(91)90165-4","article-title":"Antibodies to thymic epithelial cells in myasthenia gravis","volume":"35","author":"Safar","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.2353\/ajpath.2007.070240_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.immunol.23.021704.115601","article-title":"A central role for central tolerance","volume":"24","author":"Kyewski","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib43","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.173.5.3418","article-title":"Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat","volume":"173","author":"Daveau","year":"2004","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib44","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.1074\/jbc.M602055200","article-title":"C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1","volume":"281","author":"Fosbrink","year":"2006","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2007.070240_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-065X.2001.1800104.x","article-title":"Role of the C5b-9 complement complex in cell cycle and apoptosis","volume":"180","author":"Rus","year":"2001","journal-title":"Immunol Rev"},{"key":"10.2353\/ajpath.2007.070240_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/CS20020362","article-title":"Beyond lysis: how complement influences cell fate","volume":"104","author":"Cole","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.2353\/ajpath.2007.070240_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-1136(200004)30:2<187::AID-GLIA8>3.0.CO;2-7","article-title":"Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis","volume":"30","author":"Dashiell","year":"2000","journal-title":"Glia"},{"key":"10.2353\/ajpath.2007.070240_bib48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI0216086","article-title":"Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection","volume":"110","author":"Lin","year":"2002","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2007.070240_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.expneurol.2006.06.003","article-title":"Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia","volume":"202","author":"Kaminski","year":"2006","journal-title":"Exp Neurol"},{"key":"10.2353\/ajpath.2007.070240_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2006.03205.x","article-title":"The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice","volume":"146","author":"Morgan","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","article-title":"Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis","volume":"189","author":"Kaminski","year":"2004","journal-title":"Exp Neurol"},{"key":"10.2353\/ajpath.2007.070240_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-4598(199701)20:1<92::AID-MUS12>3.0.CO;2-3","article-title":"Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers","volume":"20","author":"Navenot","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.2353\/ajpath.2007.070240_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MN:25:1:001","article-title":"Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities","volume":"25","author":"Gasque","year":"2002","journal-title":"Mol Neurobiol"},{"key":"10.2353\/ajpath.2007.070240_bib54","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2007.070240_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib57","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","article-title":"Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen","volume":"82","author":"Matthews","year":"2002","journal-title":"Lab Invest"},{"key":"10.2353\/ajpath.2007.070240_bib58","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies","volume":"158","author":"Graus","year":"1997","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2007.070240_bib59","unstructured":"Leite M, Cossins J, Clover L, Beeson D, Willcox N, Vincent A: Antibodies to clustered AChR and thymic changes in seronegative myasthenia gravis (abstract). J Neurol Neurosurg Psychiatry (in press)"},{"key":"10.2353\/ajpath.2007.070240_bib60","first-page":"233","article-title":"The prevalence of MuSK antibody positive myasthenia gravis worldwide","volume":"178","author":"Vincent","year":"2006","journal-title":"J Neuroimmunol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010620214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010620214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:53:00Z","timestamp":1762080780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010620214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0002944010620214"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2007.070240","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia Gravis Thymus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2007.070240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}